GMTX

Gemini Therapeutics (GMTX)

Gemini Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GMTX

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/30	05 : 18	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/29	06 : 23	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/29	06 : 02	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/29	05 : 23	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/29	05 : 13	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/29	05 : 12	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/22	05 : 54	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/21	05 : 03	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/21	05 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/16	20 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/15	19 : 26	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/13	05 : 37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/13	05 : 12	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/10	07 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/10	07 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/06/09	21 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/05/15	20 : 17	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/05/15	20 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/04/20	20 : 06	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/04/20	20 : 03	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/04/20	05 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/03/31	20 : 20	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/03/31	20 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/02/25	06 : 48	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/02/17	06 : 16	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/02/15	07 : 02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/02/15	06 : 39	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/02/14	21 : 19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/02/14	03 : 45	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:GMTX	Gemini Therapeutics Inc
2023/02/10	23 : 10	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:GMTX	Gemini Therapeutics Inc